A lot of developers talk up the potential of a certain site or community. King Street Properties is putting its money where its mouth is, and doing it in Devens, a community that’s seen some major development before but never of this magnitude.
Lynch and King Street are planning to start work early in 2021 on what will eventually be a $500-million investment on a cluster of biotech manufacturing buildings. And they’re doing it on-spec, meaning without tenants lined up first, a sure sign of confidence that life science firms will need lots of more space to manufacture drugs, and a lot of Boston-area firms will want to do it close by in Devens, where the price is right.
